Skip to main content

Table 1 Patient characteristics at randomization

From: Sustaining training effects through physical activity coaching (STEP): a randomized controlled trial

 

UCG (n = 37)

IG (n = 36)

All (n = 73)

Age (years)

66 ± 8

62 ± 7

65 ± 7

Gender [n (% male)]

20 (54%)

22 (61%)

42 (58%)

BMI (kg/m2)

26 ± 5

24 ± 6

25 ± 5

FEV1(% pred)

49 ± 17

50 ± 21

49 ± 19

TL,CO(% pred)

50 ± 18

50 ± 14

50 (16)

VO2peak (ml/min/kg)

15.9 ± 4.2

18.4 ± 4.0

16.8 ± 4.2

VO2peak (% pred)

77 ± 23

78 ± 42

77 ± 33

Endurance time CWRT (s)

321 ± 143

374 ± 212

345 ± 179

6MWD (m)

499 ± 72

512 ± 79

506 ± 75

6MWD (% pred)

81 ± 12

79 ± 11

80 ± 12

Max isom QF (Nm)

137 ± 41

133 ± 52

135 ± 47

Max isom QF (Nm/kg)

1.83 ± 0.47

1.94 ± 0.55

1.89 ± 0.51

CRDQdyspnea (points)

22 ± 6

20 ± 5

21 ± 6

CRDQtotal (points)

93 ± 15

89 ± 12

91 ± 14

PA (steps/day)

5530 ± 2910

4910 ± 2352

5225 ± 2646

Time spent in MVPA (min/day)

87 ± 40

80 ± 31

83 ± 36

Movement intensity (m/s2)

1.68 ± 0.26

1.78 ± 0.21

1.73 ± 0.24

Daylight (min/day)

763 ± 183

760 ± 188

761 ± 184

Wearing time (min/day)

873 ± 95

870 ± 102

872 ± 98

Valid weekdays (n)

4.85 ± 0.44

4.78 ± 0.49

4.82 ± 0.46

  1. Values presented as mean ± standard deviation or as number (percentage). UCG, usual care group; IG, intervention group; BMI, n, number of patients; body mass index; kg, kilograms; m,meters; FEV1, forced expiratory volume in 1 s; pred, predicted; FEV1/FVC, tiffeneau index; TLCO, diffusing capacity for carbon monoxide; ; VO2, oxygen uptake; ml, millilitres; min, minutes; CWRT, constant work rate test; s, seconds; 6MWD, six minutes walking distance; Max, maximal; isom, isometric; QF, quadriceps force; Nm, Newtonmeters; CRDQ, Chronic Respiratory Disease Questionnaire; PA, physical activity; MVPA, moderate to vigorous PA.; PA data is based on DAM data (n = 65)